Drug Delivery System Uses Nanotechnology
Posted on: Thursday, 8 March 2007, 09:00 CST
U.S. scientists have developed an unusual nano-centered drug delivery system in which the drug itself acts as the delivery vehicle.
The process of efficiently delivering drugs, especially those that are hydrophobic, or water-repellant, to tumors or other disease sites has long been problematic. But now scientists at the University at Buffalo's Institute for Lasers, Photonics and Biophotonics and the Roswell Park Cancer Institute have developed a drug delivery system that uses nanocrystals measuring about 100 nanometers of pure HPPH, (2-devinyl-2-(1'-hexyloxyethyl) pyropheophorbide), a photosensitizer currently in Phase I/II human clinical trials for treating various types of cancer.
The researchers found the nanocrystals of HPPH were taken up by tumors in vivo, with efficacy comparable to conventional, surfactant-based delivery systems.
In this case, the drug itself acts as its own carrier, said Haridas Pudavar, research assistant professor of chemistry and a study co-author.
A patent application has been filed for the technique, which might also be used to deliver other hydrophobic drugs, including those used in chemotherapy.
The process is described in detail in the current issue of the journal Molecular Pharmaceutics.
Source: United Press International
Related Articles
- Drug Delivery Implants Well-Positioned for Growth in Cancer, Pain Management
- Swiss Drug Delivery Firm Licenses Fast-Acting Diclofenac Products to U.S. Based ProEthic Pharmaceuticals
- SCOLR Pharma, Inc. Issued Second Patent for Platform Used to Formulate Challenging Drugs; Broadens Application of CDT Drug Delivery Platform As Alternative Technology
- Kurve Technology Invited to Speak at SRI's Drug Delivery Technologies and Deal Making Summit
- Drug Delivery Technologies & Deal-Making Summit 10th Year Anniversary Meeting
- Aegis Therapeutics' Intravail(TM) Drug Delivery Technology Gaining Acceptance
- Merrion Pharmaceuticals, Inc. Is Issued a United States Drug Delivery System Patent
- FzioMed Reports Promising Results of Novel Bone Growth Factor in Preclinical Studies and Demonstrates Oxiplex Gel As Effective Drug Delivery Platform
- New Drug Delivery Technologies Aim at Improving Overall Therapeutic Benefits
- Epidermal Growth Factor Receptor (EGFR)-Targeted Immunoliposomes Mediate Specific and Efficient Drug Delivery to EGFR- and EGFRvIII- Overexpressing Tumor Cells
 |
 |
User Comments (0)
RSS Feeds